PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism

被引:336
作者
Medina-Gomez, Gema
Gray, Sarah L.
Yetukuri, Laxman
Shimomura, Kenju
Virtue, Sam
Campbell, Mark
Curtis, R. Keira
Jimenez-Linan, Mercedes
Blount, Margaret
Yeo, Giles S. H.
Lopez, Miguel
Seppanen-Laakso, Tuulikki
Ashcroft, Frances M.
Oresic, Matej
Vidal-Puig, Antonio [1 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem Histopathol, Cambridge CB2 1TN, England
[2] Tech Res Ctr Finland, VTT, Espoo, Finland
[3] Univ Oxford, Physiol Lab, Oxford OX1 2JD, England
来源
PLOS GENETICS | 2007年 / 3卷 / 04期
基金
英国医学研究理事会;
关键词
D O I
10.1371/journal.pgen.0030064
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Peroxisome proliferator activated receptor gamma 2 (PPARg2) is the nutritionally regulated isoform of PPARg. Ablation of PPARg2 in the ob/ob background, PPARg2(-/-) Lep(ob)/Lep(ob) (POKO mouse), resulted in decreased fat mass, severe insulin resistance, beta-cell failure, and dyslipidaemia. Our results indicate that the PPARg2 isoform plays an important role, mediating adipose tissue expansion in response to positive energy balance. Lipidomic analyses suggest that PPARg2 plays an important antilipotoxic role when induced ectopically in liver and muscle by facilitating deposition of fat as relatively harmless triacylglycerol species and thus preventing accumulation of reactive lipid species. Our data also indicate that PPARg2 may be required for the beta-cell hypertrophic adaptive response to insulin resistance. In summary, the PPARg2 isoform prevents lipotoxicity by ( a) promoting adipose tissue expansion, (b) increasing the lipid-buffering capacity of peripheral organs, and ( c) facilitating the adaptive proliferative response of beta-cells to insulin resistance.
引用
收藏
页码:0634 / 0647
页数:14
相关论文
共 59 条
  • [41] PPARγ is required for the differentiation of adipose tissue in vivo and in vitro
    Rosen, ED
    Sarraf, P
    Troy, AE
    Bradwin, G
    Moore, K
    Milstone, DS
    Spiegelman, BM
    Mortensen, RM
    [J]. MOLECULAR CELL, 1999, 4 (04) : 611 - 617
  • [42] Molecular regulation of adipogenesis
    Rosen, ED
    Spiegelman, BM
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2000, 16 : 145 - 171
  • [43] TARGETED EXPRESSION OF A TOXIN GENE TO ADIPOSE-TISSUE - TRANSGENIC MICE RESISTANT TO OBESITY
    ROSS, SR
    GRAVES, RA
    SPIEGELMAN, BM
    [J]. GENES & DEVELOPMENT, 1993, 7 (7B) : 1318 - 1324
  • [44] Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy
    Shimomura, I
    Hammer, RE
    Richardson, JA
    Ikemoto, S
    Bashmakov, Y
    Goldstein, JL
    Brown, MS
    [J]. GENES & DEVELOPMENT, 1998, 12 (20) : 3182 - 3194
  • [45] PPAR-γ:: Adipogenic regulator and thiazolidinedione receptor
    Spiegelman, BM
    [J]. DIABETES, 1998, 47 (04) : 507 - 514
  • [46] Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction of L-type amino acid transporter 1 and cell surface antigen 4F2
    Takabe, W
    Kanai, Y
    Chairoungdua, A
    Shibata, N
    Toi, S
    Kobayashi, M
    Kodama, T
    Noguchi, N
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (09) : 1640 - 1645
  • [47] Minireview: Weapons of lean body mass destruction: The role of ectopic lipids in the metabolic syndrome
    Unger, RH
    [J]. ENDOCRINOLOGY, 2003, 144 (12) : 5159 - 5165
  • [48] Lipoapoptosis: its mechanism and its diseases
    Unger, RH
    Orci, L
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1585 (2-3): : 202 - 212
  • [49] Energy metabolism in uncoupling protein 3 gene knockout mice
    Vidal-Puig, AJ
    Grujic, D
    Zhang, CY
    Hagen, T
    Boss, O
    Ido, Y
    Szczepanik, A
    Wade, J
    Mootha, V
    Cortright, R
    Muoio, DM
    Lowell, BB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (21) : 16258 - 16266
  • [50] Regulation of PPAR gamma gene expression by nutrition and obesity in rodents
    VidalPuig, A
    JimenezLinan, M
    Lowell, BB
    Hamann, A
    Hu, E
    Spiegelman, B
    Flier, JS
    Moller, DE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) : 2553 - 2561